Increased levels of plasma cholesteryl ester hydroperoxides in patients with subarachnoid hemorrhage

Free Radical Biology and Medicine

Volumn 23, Issue 5, 1997, Pages 762-767

  Polidari, M Cristina ^a,b   Frei, Balz ^b   Rordorf, Guy ^a   Ogilvy, Christopher S ^a   Koroshetz, Walter J ^a   Beal, M Flint ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cerebral vasospasm; Free radicals; Lipid peroxides; Oxiditive stress; Subarachnoid hemorrhage

Indexed keywords

CHOLESTEROL ESTER; CHOLESTERYL ESTER HYDROPEROXIDE; HYDROPEROXIDE; UNCLASSIFIED DRUG;

ARTICLE; BLOOD LEVEL; CONTROLLED STUDY; HUMAN; LIPID PEROXIDATION; MORTALITY; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROGNOSIS; SUBARACHNOID HEMORRHAGE; VASOSPASM;

ADULT; AGED; AGED, 80 AND OVER; ANTIOXIDANTS; ASCORBIC ACID; BIOLOGICAL MARKERS; CHOLESTEROL ESTERS; FEMALE; HUMANS; LIPID PEROXIDES; MALE; MIDDLE AGED; OXIDATION-REDUCTION; SEVERITY OF ILLNESS INDEX; SUBARACHNOID HEMORRHAGE; UBIQUINONE; URIC ACID; VITAMIN E;

EID: 0030805647     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0891-5849(97)00053-1     Document Type: Article

References (46)

1. Kopitnik T. A., Sampson D. S. Management of subarachnoid hemorrhage. J. Neurol. Neurosurg. Psychiatry. 56:1993;947-953.
2. Haley E. C. Jr, Kassell N. F., Torner J. C. The International Cooperative Study on the timing of aneurismal surgery. Stroke. 23:1992;205-511.
3. Braughler J. M., Hall E. D. Central nervous system trauma and stroke: I - Biochemical considerations for oxygen radical formation and lipid peroxidation. Free Radic. Biol. Med. 6:1989;289-301.
4. Sano K., Asano T., Tanishima T., Sasaki T. Lipid peroxidation as a cause of cerebral vasospasm. Neurol. Res. 2:1980;253-272.
5. 2a, in the rat. J. Clin. Invest. 90:1992;136-141.
6. Frei B., Stocker R., Ames B. N. Antioxidant defenses and lipid peroxidation in human blood plasma. Proc. Natl. Acad. Sci. USA. 85:1988;9748-9752.
7. Halliwell B. Reactive oxygen species and the central nervous system. J. Neurochem. 59:1992;1609-1623.
8. Chyatte D., Sundt T. M. Response of chronic experimental cerebral vasospasm to methylprednisolone and dexamethasone. J. Neurosurg. 60:1984;923-926.
9. Braughler J. M. Lipid peroxidation-induced inhibition of γ -aminobutyric acid uptake in rat brain synaptosomes: Protection by glucocorticoids. J. Neurochem. 44:1985;1282-1288.
10. Travis M. A., Hall E. D. The effects of chronic two-fold dietary vitamin E supplementation on subarachnoid hemorrhage-induced brain hypoperfusion. Brain Res. 418:1987;366-370.
11. Travis M. A., Yonkers P. A., Hall E. D. Attenuation of post-hemorrhagic and post-ischemic cerebral hypoperfusion by the 21-aminosteroid U74006F, a poent inhibitor of iron-dependent lipid peroxidation. Soc. Neurosci. Abstr. 13:1987;1494.
12. Hunt W. E., Hess R. M. Surgical risk as related to time of intervention in the repair of intracranial aneurysms. J. Neurosurg. 28:1968;14-20.
13. Adams H. P., Bendixen B. H., Kappelle L. J., Biller J., Love B. B., Gordon D. L., Marsh E. E. Classification of subtype and acute ischemic stroke. Stroke. 24:1993;35-41.
14. Bowry V. M., Stanley K. K., Stocker R. High density lipoprotein is the major carrier of lipid hydroperoxides in human blood plasma from fasting donors. Proc. Natl. Acad. Sci. USA. 89:1992;10316-10320.
15. Frei B., Yamamoto Y., Niclas D., Ames B. N. Evaluation of an isoluminol chemiluminescence assay for the detection of hydroperoxides in human blood plasma. Anal. Biochem. 175:1988;120-1130.
16. Yamamoto Y., Frei B., Ames B. N. Assay of lipid hydroperoxides using high-performance liquid chromatography with isoluminol chemiluminescence detection. Methods Enzymol. 186:1990;371-380.
17. Kappus H. Lipid peroxidation: Mechanisms, analysis, enzymology, and biological relevance. Sies H. Oxidative stress. 1985;273-310 Academic Press, London.
18. Sies H., Stahl W., Sundquist A. R. Antioxidant functions of vitamins. Ann. NY Acad. Sci. 669:1992;7-20.
19. Tanishima T. Cerebral vasospasm: Contractile activity of hemoglobin in isolated canine basilar arteries. J. Neurosurg. 1980:53;787-793.
20. Liszczak T. M., Varsos V. G., Black P. M., Kistler J. P., Zervas N. T. Cerebral arterial constriction after experimental subarachnoid hemorrhage is associated with blood components within the arterial wall. J. Neurosurg. 58:1983;18-26.
21. Macdonald R. L., Weir B. K. A. A review of hemoglobin and the pathogenesis of cerebral vasospasm. Stroke. 22:1991;971-982.
22. Macdonald R. L., Weir B. K. A. Cerebral vasospasm and free radicals. Free Radic. Biol. Med. 16:1994;633-643.
23. Faraci F. M., Brian J. E. Jr. Nitric oxide and the cerebral circulation. Stroke. 25:1994;692-703.
24. Fisher C. M., Kistler J. P., Davis J. M. Relation of cerebral vasospasm to subarachnoid hemorrhage visualized by computerized tomographic scanning. Neurosurgery. 6:1980;1-9.
25. Takenaka K., Kassel N., Foley P., Lee K. Oxyhemoglobin-induced cytotoxicity and arachidonic acid release in cultured bovine endothelial cells. Stroke. 24:1994;839-846.
26. Mayberg M. R., Okada T., Bark D. The significance of morphological changes in cerebral arteries after subarachnoid hemorrhage. J. Neurosurg. 72:1990;626-633.
27. Sakaki S., Ohta S., Nakamura H., Takeda S. Free radical reaction and biological defense mechanism in the pathogenesis of prolonged vasospasm in experimental subarachnoid hemorrhage. J. Cereb. Blood Flow Metab. 8:1988;1-8.
28. Macdonald R. L., Weir B. K. A., Runzer T. D., Grace G. A. Malondialdehyde, glutathione peroxidase and superoxide dismutase in cerebrospinal fluid during cerebral vasospasm in monkeys. Can. J. Neurol. Sci. 19:1992;326-332.
29. Saski T., Wakai S., Asano T., Watanabe T., Kirino T., Sano K. The effect of a lipid peroxide of arachidonic acid on the canine basilar artery. An experimental study on cerebral vasospasm. J. Neurosurg. 54:1981;357-365.
30. Asano T., Sasaki T., Koide T., Takakura K., Sano K. Experimental evaluation of the beneficial effect of an antioxidant on cerebral vasospasm. Neurol. Res. 6:1984;49-53.
31. Harada T., Mayberg M. Inhibition of delayed arterial narrowing by the iron-chelating agent deferoxamine. J. Neurosurg. 77:1992;763-767.
32. Luo Z., Harada T., London S., Gajdusek C., Mayberg M. R. Antioxidant and iron-chelating agents in cerebral vasospasm. Neurosurgery. 37:1995;1154-1158.
33. Shishido T., Suzuki R., Qian L., Niimi Y., Masaoka H., Hirakawa K. Human recombinant superoxide dismutase prevents cerebral vasospasm in a rabbit subarachnoid hemorrhage model. Can. J. Neurol. Sci. 20:1993;513.
34. Vollmer D. G., Hongo K., Ogawa H., Tsukahara T., Kassel N. F. A study of the effectiveness of the iron-chelating agent deferoxamine as vasospasm prophyilaxis in a rabbit model of subarachnoid hemorrhage. Neurosurgery. 28:1991;27-32.
35. Hillered L., Persson L. Parabanic acid for monitoring of oxygen radical activity in the injured human brain. Neuroreport. 6:1995;1816-1820.
36. Sasaki T., Tanishima T., Asano T., Mayanagi Y., Sano K. Significance of lipid peroxidation in the genesis of chronic vasospasm following rupture of an intracranial aneurysm. Acta Neurochir. 28:1979;536-540.
37. Sasaki T., Asano T., Sano K. Cerebral vasospasm and free radical reactions. Neurol. Med. Chir. (Tokyo). 20:1980;145-153.
38. Kuwabara H., Sakaki S., Nakano K., Yano M., Hatakeyama T., Matsuoka K. A study on the changes of superoxide dismutase activities and the amount of lipid peroxide in patients with ruptured intracranial aneurysms with special reference to the pathogenesis of vasospasm. Nosochu. No. Geta. 11:1982;159-164.
39. Watanabe T., Nishiyama M., Okamoto H., Hori T., Asano T., Masayasu H. Effects of ebselen on experimental cerebral vasospasm. Wendall A. Selenium in biology and medicine. 1988;117-184 Springer Verlag, New York.
40. Haley E. C., Kassel N. F., Alves W. M., Weir B. K. A., Apperson-Hansen C. Phase II trial of tirilazad in aneurysmal subarachnoid hemorrhage. J. Neurosurg. 82:1995;786-790.
41. Kassel N. F., Haley E. C., Apperson-Hansen C., Alves W. M. A randomized double-blind, vehicle-controlled trial of tirilazad mesylate in patients with aneurysmal subarachnoid hemorrhage: A cooperative study in Europe/Australia/New Zealand. J. Neurosurg. 84:1996;221-228.
42. Malenka R., Kauer J., Perkel D., Nicoll R. The impact of postsynaptic calcium on synaptic transmission its role in long-term potentiation. Trends Neurosci. 12:1989;444-450.
43. Dexter D. T., Holley A. E., Flitter W. D., Slater T. F., Wells F. R., Daniel S. E., Lees A. J., Jenner P., Marsden C. D. Increased levels of lipid hydroperoxides in the Parkinsonian substantia nigra: An HPLC and ESR study. Movement Disord. 9:1994;92-97.
44. Galley H. F., Davies M. J., Webster N. R. Ascorbyl radical formation in patients with sepsis: Effect of ascorbate loading. Free Radic. Biol. Med. 20:1996;139-143.
45. Goode H. F., Cowley H. C., Walker B. E., Howdle P. D., Webster N. R. Decreased antioxidant status and increased lipid peroxidation in patients with septic shock and secondary organ dysfunction. Crit. Care Med. 23:1995;646-651.
46. Bochicchio M., Latronico N., Zani D. G., Mariotti M., Morandini L., Acquarolo A. M., Candiani A. Free radical-induced lipoperoxidation and severe head injury. Intensive Care Med. 16:1990;444-447.